Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-15 Purchase |
2023-09-28 06:15 am |
OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director |
16,670 | $1.5 | $25,005 | 16,670 (Direct) |
View |
| 2021-03-22 Purchase |
2021-03-22 6:35 pm |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
3,000 | $10.95 | $32,850 | 12,260 (Direct) |
View |
| 2020-12-02 Purchase |
2020-12-02 6:05 pm |
Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Director |
7,000 | $1.53 | $10,710 | 7,008 (Direct) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:16 pm |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
6,993 | $1.43 | $10,000 | 9,260 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-19 Option Award |
2024-02-21 8:01 pm |
2024-02-19 2034-02-19 |
Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Chairman |
85,000 | $0 | 99,563 (Direct) |
View |
| 2022-06-09 Other |
2022-06-09 7:48 pm |
2022-06-09 2024-06-09 |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Former Director Director |
124,318 | $0 | 1,127,853 (Direct) |
View |
Ownership |
2022-05-16 5:47 pm |
N/A 2028-08-19 |
OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director |
0 | $0 | 1,450,000 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-10 6:38 pm |
2023-03-09 2032-03-09 |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
26,800 | $0 | 125,317 (Direct) |
View |
Ownership |
2021-12-03 4:15 pm |
N/A 2031-08-01 |
Accustem Sciences Inc. | ACMSY | BRANCACCIO JOHN P Director |
0 | $0 | 8,964 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 4:11 pm |
2022-06-10 2031-06-10 |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
22,000 | $0 | 98,517 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-20 4:34 pm |
2022-05-18 2031-05-18 |
Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Director |
200,000 | $0 | 291,332 (Direct) |
View |
| 2020-08-19 Option Award |
2020-08-21 4:16 pm |
2021-08-19 2030-08-19 |
Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Director |
30,000 | $0 | 91,332 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:16 pm |
2021-06-17 2030-06-17 |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
28,858 | $0 | 76,517 (Direct) |
View |